Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Kolterman Orville G
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
Avg. Two Year Performance
No purchase track record
15%
Avg. Sale Return
7%
Compound
1 Mo
3 Mo
6 Mo
1 Yr
2 Yr
Average Purchase Return
--
--
--
--
--
Purchase Success Rate
--
--
--
--
--
Average Sale Return
< 1%
3%
6%
23%
15%
Sale Success Rate
18 of 39
18 of 39
19 of 39
23 of 39
15 of 39
Amylin Pharmaceuticals Inc.
Drugs
» Biotechnology
SVP, Chief Medical Officer:
Holdings: 0 shares
Sentiment
Avg. Two Year Performance
No purchase track record
No sale track record
Last Three Months:
0
Net Amount
Buy:
0
--
Sell:
0
--